feed,title,long_url,short_url
Benzinga,Cytokinetics Post-Hoc Data Suggests Omecamtiv Mecarbil Works Better In High-Risk Patients For Heart Failure,https://benzinga.com/general/biotech/21/05/21154776/cytokinetics-post-hoc-data-suggests-omecamtiv-mecarbil-works-better-in-high-risk-patients-for-hea,https://j.mp/3orUXJI
